Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Galanin peptide family as a modulating target for contribution to metabolic syndrome.

Fang P, Yu M, Shi M, Zhang Z, Sui Y, Guo L, Bo P.

Gen Comp Endocrinol. 2012 Oct 1;179(1):115-20. doi: 10.1016/j.ygcen.2012.07.029. Epub 2012 Aug 14. Review.

PMID:
22909974
2.

Galanin and its receptors: a novel strategy for appetite control and obesity therapy.

Fang P, Yu M, Guo L, Bo P, Zhang Z, Shi M.

Peptides. 2012 Aug;36(2):331-9. doi: 10.1016/j.peptides.2012.05.016. Epub 2012 Jun 2. Review.

PMID:
22664322
4.
5.

The developmental origins, mechanisms, and implications of metabolic syndrome.

Bruce KD, Hanson MA.

J Nutr. 2010 Mar;140(3):648-52. doi: 10.3945/jn.109.111179. Epub 2010 Jan 27. Review.

PMID:
20107145
6.
7.

The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease.

Lang R, Gundlach AL, Kofler B.

Pharmacol Ther. 2007 Aug;115(2):177-207. Epub 2007 May 31. Review.

PMID:
17604107
8.

Obesity and metabolic syndrome: potential benefit from specific nutritional components.

Abete I, Goyenechea E, Zulet MA, Martínez JA.

Nutr Metab Cardiovasc Dis. 2011 Sep;21 Suppl 2:B1-15. doi: 10.1016/j.numecd.2011.05.001. Epub 2011 Jul 20. Review.

PMID:
21764273
10.
11.

The role of galanin in metabolic disorders leading to type 2 diabetes mellitus.

Legakis IN.

Drug News Perspect. 2005 Apr;18(3):173-7. Review.

PMID:
15915218
12.

The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.

Chan JC, Tong PC, Critchley JA.

Semin Vasc Med. 2002 Feb;2(1):45-57. Review.

PMID:
16222595
13.

Type 2 diabetes mellitus as a disorder of galanin resistance.

Fang P, Shi M, Zhu Y, Bo P, Zhang Z.

Exp Gerontol. 2016 Jan;73:72-7. doi: 10.1016/j.exger.2015.11.007. Epub 2015 Nov 14. Review.

PMID:
26585047
14.

The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction.

Traish AM, Guay A, Feeley R, Saad F.

J Androl. 2009 Jan-Feb;30(1):10-22. doi: 10.2164/jandrol.108.005215. Epub 2008 Jul 17. Review.

15.

Galanin in the PVN increases nutrient intake and changes peripheral hormone levels in the rat.

Kyrkouli SE, Strubbe JH, Scheurink AJ.

Physiol Behav. 2006 Aug 30;89(1):103-9. Epub 2006 Jun 27.

PMID:
16806319
16.

Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease.

Frisardi V, Solfrizzi V, Seripa D, Capurso C, Santamato A, Sancarlo D, Vendemiale G, Pilotto A, Panza F.

Ageing Res Rev. 2010 Oct;9(4):399-417. doi: 10.1016/j.arr.2010.04.007. Epub 2010 May 2. Review.

PMID:
20444434
18.

Feeding behaviour in galanin knockout mice supports a role of galanin in fat intake and preference.

Adams AC, Clapham JC, Wynick D, Speakman JR.

J Neuroendocrinol. 2008 Feb;20(2):199-206. Epub 2007 Dec 14.

PMID:
18088361
19.

High-carbohydrate high-fat diet–induced metabolic syndrome and cardiovascular remodeling in rats.

Panchal SK, Poudyal H, Iyer A, Nazer R, Alam A, Diwan V, Kauter K, Sernia C, Campbell F, Ward L, Gobe G, Fenning A, Brown L.

J Cardiovasc Pharmacol. 2011 Jan;57(1):51-64. doi: 10.1097/FJC.0b013e3181feb90a. Erratum in: J Cardiovasc Pharmacol. 2011 May;57(5):610. Corrected and republished in: J Cardiovasc Pharmacol. 2011 May;57(5):611-24.

PMID:
20966763
20.

Central nervous system regulation of food intake and energy expenditure: role of galanin-mediated feeding behavior.

Fang PH, Yu M, Ma YP, Li J, Sui YM, Shi MY.

Neurosci Bull. 2011 Dec;27(6):407-12. doi: 10.1007/s12264-011-1841-7. Review.

Supplemental Content

Support Center